<DOC>
	<DOC>NCT01655290</DOC>
	<brief_summary>This study aims at evaluating the diagnostic efficacy of Gadobutrol versus Gadobenate dimeglumine at similar dose of 0.1mmol/kg for assessment of myocardial infarction by delayed enhancement cardiac Magnetic Resonance Imaging</brief_summary>
	<brief_title>Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Diagnosis of myocardial infarction Age ≥ 18 years and ≤ 80 years Informed consent Male patients as well as female patients using contraceptives Patients with a heart pacemaker, with magnetic material or other magnetic implants. Renal failure (GFR &lt;30ml/min) Patients with known allergy to a Gadoliniumcontaining contrast agent Drugs or alcohol addiction, dementia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>